549 related articles for article (PubMed ID: 33063712)
1. The emerging role of probiotics in neurodegenerative diseases: new hope for Parkinson's disease?
Castelli V; d'Angelo M; Quintiliani M; Benedetti E; Cifone MG; Cimini A
Neural Regen Res; 2021 Apr; 16(4):628-634. PubMed ID: 33063712
[TBL] [Abstract][Full Text] [Related]
2. Mind-altering with the gut: Modulation of the gut-brain axis with probiotics.
Kim N; Yun M; Oh YJ; Choi HJ
J Microbiol; 2018 Mar; 56(3):172-182. PubMed ID: 29492874
[TBL] [Abstract][Full Text] [Related]
3. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
Caputi V; Giron MC
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798
[TBL] [Abstract][Full Text] [Related]
4. The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options.
Wang Q; Luo Y; Ray Chaudhuri K; Reynolds R; Tan EK; Pettersson S
Brain; 2021 Oct; 144(9):2571-2593. PubMed ID: 33856024
[TBL] [Abstract][Full Text] [Related]
5. Parkinson's disease: Are gut microbes involved?
Omotosho AO; Tajudeen YA; Oladipo HJ; Yusuff SI; AbdulKadir M; Muili AO; Egbewande OM; Yusuf RO; Faniran ZO; Afolabi AO; El-Sherbini MS
Brain Behav; 2023 Aug; 13(8):e3130. PubMed ID: 37340511
[TBL] [Abstract][Full Text] [Related]
6. Microbiota- Brain-Gut-Axis Relevance to Parkinson's Disease: Potential Therapeutic Effects of Probiotics.
Raj K; Singh S; Chib S; Mallan S
Curr Pharm Des; 2022; 28(37):3049-3067. PubMed ID: 36200207
[TBL] [Abstract][Full Text] [Related]
7. Gut brain axis: an insight into microbiota role in Parkinson's disease.
Moustafa SA; Mohamed S; Dawood A; Azar J; Elmorsy E; Rizk NAM; Salama M
Metab Brain Dis; 2021 Oct; 36(7):1545-1557. PubMed ID: 34370175
[TBL] [Abstract][Full Text] [Related]
8. Are We What We Eat? Impact of Diet on the Gut-Brain Axis in Parkinson's Disease.
Alfonsetti M; Castelli V; d'Angelo M
Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057561
[TBL] [Abstract][Full Text] [Related]
9. Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinson's Disease.
Kaur G; Behl T; Bungau S; Kumar A; Uddin MS; Mehta V; Zengin G; Mathew B; Shah MA; Arora S
Curr Neuropharmacol; 2021; 19(2):233-247. PubMed ID: 32504503
[TBL] [Abstract][Full Text] [Related]
10. Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle.
Chidambaram SB; Essa MM; Rathipriya AG; Bishir M; Ray B; Mahalakshmi AM; Tousif AH; Sakharkar MK; Kashyap RS; Friedland RP; Monaghan TM
Pharmacol Ther; 2022 Mar; 231():107988. PubMed ID: 34536490
[TBL] [Abstract][Full Text] [Related]
11. Effects of the probiotic formulation SLAB51 in
Castelli V; d'Angelo M; Lombardi F; Alfonsetti M; Antonosante A; Catanesi M; Benedetti E; Palumbo P; Cifone MG; Giordano A; Desideri G; Cimini A
Aging (Albany NY); 2020 Mar; 12(5):4641-4659. PubMed ID: 32155131
[TBL] [Abstract][Full Text] [Related]
12. Unraveling the gut-brain axis: the impact of steroid hormones and nutrition on Parkinson's disease.
Neufeld PM; Nettersheim RA; Matschke V; Vorgerd M; Stahlke S; Theiss C
Neural Regen Res; 2024 Oct; 19(10):2219-2228. PubMed ID: 38488556
[TBL] [Abstract][Full Text] [Related]
13. The Interaction Between Nutraceuticals and Gut Microbiota: a Novel Therapeutic Approach to Prevent and Treatment Parkinson's Disease.
Yao L; Yang Y; Yang X; Rezaei MJ
Mol Neurobiol; 2024 Apr; ():. PubMed ID: 38587699
[TBL] [Abstract][Full Text] [Related]
14. Dysbiosis is one of the risk factor for stroke and cognitive impairment and potential target for treatment.
Koszewicz M; Jaroch J; Brzecka A; Ejma M; Budrewicz S; Mikhaleva LM; Muresanu C; Schield P; Somasundaram SG; Kirkland CE; Avila-Rodriguez M; Aliev G
Pharmacol Res; 2021 Feb; 164():105277. PubMed ID: 33166735
[TBL] [Abstract][Full Text] [Related]
15. The Role of Microbiome in Brain Development and Neurodegenerative Diseases.
Nandwana V; Nandwana NK; Das Y; Saito M; Panda T; Das S; Almaguel F; Hosmane NS; Das BC
Molecules; 2022 May; 27(11):. PubMed ID: 35684340
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic Insights Into Gut Microbiome Dysbiosis-Mediated Neuroimmune Dysregulation and Protein Misfolding and Clearance in the Pathogenesis of Chronic Neurodegenerative Disorders.
Padhi P; Worth C; Zenitsky G; Jin H; Sambamurti K; Anantharam V; Kanthasamy A; Kanthasamy AG
Front Neurosci; 2022; 16():836605. PubMed ID: 35281490
[TBL] [Abstract][Full Text] [Related]
17. Role of the Gut-Brain Axis, Gut Microbial Composition, Diet, and Probiotic Intervention in Parkinson's Disease.
Thangaleela S; Sivamaruthi BS; Kesika P; Bharathi M; Chaiyasut C
Microorganisms; 2022 Jul; 10(8):. PubMed ID: 36013962
[TBL] [Abstract][Full Text] [Related]
18. Correlation between the gut microbiome and neurodegenerative diseases: a review of metagenomics evidence.
Liu X; Liu Y; Liu J; Zhang H; Shan C; Guo Y; Gong X; Cui M; Li X; Tang M
Neural Regen Res; 2024 Apr; 19(4):833-845. PubMed ID: 37843219
[TBL] [Abstract][Full Text] [Related]
19. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
Sun MF; Shen YQ
Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
[TBL] [Abstract][Full Text] [Related]
20. The Interplay between Gut Microbiota and Parkinson's Disease: Implications on Diagnosis and Treatment.
Varesi A; Campagnoli LIM; Fahmideh F; Pierella E; Romeo M; Ricevuti G; Nicoletta M; Chirumbolo S; Pascale A
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
